Sigitas Verselis

Heterozygous Germ Line <i>hCHK2</i> Mutations in Li-Fraumeni Syndrome

Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo et al. · Science · 1999 · 902 citations

Life Sciences, Genetics, Molecular Genetics +17

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism

Evdoxia Hatjiharissi, Lian Xu, Daniel Santos et al. · Blood · 2007 · 266 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia

Steven P. Treon, Mark Hansen, Andrew R. Branagan et al. · Journal of Clinical Oncology · 2005 · 257 citations · Full text

Life Sciences, Genetics, Immunology +15

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

Yi‐Bin Chen, Shuli Li, Andrew A. Lane et al. · Biology of Blood and Marrow Transplantation · 2014 · 234 citations · Full text

Medicine, Hematology, Oncology +16

Gastric cancer in individuals with Li-Fraumeni syndrome

Serena Masciari, Akriti Dewanwala, Elena M. Stoffel et al. · Genetics in Medicine · 2011 · 146 citations · Full text

Medicine, Oncology, Pathology +14